Thyroid Science
3(6)CR1-3, 2008
Utility of Adrenal
Cortical Scintigraphy with
131I-6-β-Methyl-
Norcholesterol in a Case of Mismatch Between
Morphological and Functional PET Imaging
(Full
Text Free in pdf format)
Laura Evangelista,* Teresa De Falco,* Carmine di Nuzzo,
Marco Salvatore
*Department of Biomorphological and Functional Sciences
University Federico II, Via S. Pansini, 5, I-80131 Napoli, Italy
Contacts:
laura.evangelista@tin.it &
teresadefalco@yahoo.it
Introduction
John C. Lowe, MA, DC: Editor-in-Chief
(Full
Text Free in pdf format)
We are pleased to publish this case report by
Evangelista, De Falco, di Nuzzo, and Salvatore. These Italian physicians describe a patient
whose presenting complaint was abdominal pain but who was then found to
have an adrenal cortical adenoma.
Many clinicians who correspond with us at Thyroid Science ask if
we will publish papers on adrenal dysfunctions. As these disorders are so
often related to thyroid dysfunction, our answer has been yes. According
to our communications, most clinicians find that their thyroid patients
have cortisol deficiencies, yet others have unexplained elevated cortisol
levels.
The patient of Evangelista et al. had elevated renin rather than
cortisol. They found the source to be an adrenal cortical "incidentaloma."
An incidentaloma is an unexpected finding of an adenoma during a
diagnostic procedure performed to learn the source of a patient’s
abdominal symptoms.
The authors performed adrenal scintigraphy using "NCL-6-I." NCL-6-I is
a radioactive agent taken up by the adrenal glands some ten-times more
than alternative agents.[1] By measuring its accumulation in the adrenal
gland by scintigraphy, it functions as an effective radioactive tracer.
Resulting scintigrams are the photographic record that indicates the
intensity and distribution of radioactivity in parts of the adrenal glands
after the diagnostician administers the radioactive tracer. The authors
provide three such scintigrams. They note that adrenocortical
radiocholesterol scintigraphy, in which they used NCL-6-I, is the most
accurate non-invasive imaging technique in differentiating benign cortical
adenomas from space-occupying or destructive adrenal lesions. They point
out that the faint uptake of the tracer in the patient indicated an
adrenal cortical adenoma.
We would especially like to note a precaution from the authors. That is,
in the population at large, adrenal adenomas are fairly common, ranging
between 2% and 9%. The authors emphasize the importance of the incidental
detection of such adrenal lesions, especially for the patient with a
previous malignancy.
This case report is one of the few published since 1996 on the value of
adrenal scintigraphy with NCL-6-I. We are proud to add this case report to
the literature on this tracer. We believe that knowledge of the diagnostic
procedure will be of value to some clinicians trying to determine why some
patients have high adrenocortical hormone levels—especially high cortisol
levels not explained by common mechanisms such as pain, inflammation,
glycemic dysregulation, or psychologically-induced stress.
Reference:
1. Kojima, M., Maeda, M., Ogawa, H. et al.: New adrenal-scanning agent.
J. Nuclear Med., 16(7):666-668,
1975.
Key Words. Adrenal cortex •
Computed tomography • 131I-6-ß-methyl-Norcholesterol •
Incidentalomas • Scintigraphy •
Evangelista, L., Teresa De Falco, T., Carmine di Nuzzo, C., Salvatore,
M.: Utility of adrenal cortical scintigraphy with 131I-6-β-Methyl-Norcholesterol
in a case of mismatch between morphological and functional PET imaging.
Thyroid Science, 3(6):CR1-3, 2008.
|
(Full
Text Free in pdf format)
© 2008 Thyroid Science |